Published in:
01-08-2009 | Original Paper
Viral and non-viral risk factors for non-Hodgkin’s lymphoma in Egypt: heterogeneity by histological and immunological subtypes
Authors:
Lenka Goldman, Sameera Ezzat, Nadia Mokhtar, Amany Abdel-Hamid, Nathan Fowler, Iman Gouda, Soheir Abdel Latif Eissa, Mohamed Abdel-Hamid, Christopher A. Loffredo
Published in:
Cancer Causes & Control
|
Issue 6/2009
Login to get access
Abstract
Objective
Non-Hodgkin’s lymphomas (NHL) are etiologically heterogeneous malignancies. In Egypt, we previously reported an association of increased NHL risk with chronic hepatitis C virus (HCV) infection. Our present aim is to assess the association between HCV infection and histological subtypes of NHL.
Methods
We conducted a case–control study at the National Cancer Institute of Cairo University. Cases with NHL (n = 486) were matched to controls (n = 786) who were orthopedic patients from the same referral regions. Participants provided a blood sample for HCV markers (anti-HCV, HCV RNA) and answered a questionnaire on possible risk factors. Case–control differences were assessed by odds ratios and 95% confidence intervals from logistic regression analysis.
Results
Cases with diffuse large B cell lymphoma (n = 146), chronic lymphocytic leukemia (n = 58), marginal zone lymphoma (n = 24), follicular lymphoma (n = 23), and mantle cell lymphoma (n = 16) were recruited. HCV RNA prevalence was 27% in controls and 26%–48% in the NHL subgroups: it was associated (p < 0.001) with diffuse large B cell, marginal zone, and follicular lymphomas with odds ratios of 3.2, 4.4, and 3.3, respectively.
Conclusion
HCV is a risk factor for diffuse large B cell, marginal zone, and follicular lymphomas in Egypt.